CD274 and cancer: DCs have the potential to express PD‐L1 on their surface (90), and studies on other cancers, including colorectal cancer, have discovered that PD‐L1 positive DCs are better predictors of response to anti-PD‐L1 immunotherapy compared to PD‐L1+ tumor cells (91).